-
Gut microbiome helps shape Parkinson’s drug interactions
Drug-microbiome-drug interaction study reveals how COMT inhibitors used with levodopa alter gut bacteria and affect medication metabolism in Parkinson's patients.
-
Gut microbiota metabolic reprogramming may drive metabolic disease
Dysbiosis-induced microbial metabolic reprogramming drives metabolic disease through alterations in lipid, glucose, amino acid, and uric acid metabolism.
-
Ecological network balance index distinguishes healthy and dysbiotic gut states
Ecological network balance index quantifies positive and negative microbial interactions as a marker of dysbiosis, differentiating health from disease states with mechanistic grounding.
-
Gut microbiome is linked to colorectal cancer development and management
Review of gut microbiome mechanisms in colorectal cancer carcinogenesis, examining pathogenic bacteria, protective functions, biomarker development, and therapeutic strategies.
-
Baby-to-baby transmission shapes the infant gut microbiome
Study reveals how baby-to-baby microbiome transmission in nurseries substantially shapes infant gut health during the first year, complementing maternal microbial inheritance.